Trustwave Securities Regulatory Approval

Board Meeting Date

Trustwave Securities Board Meeting Date

Trustwave Securities intimated a board meeting on 04 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results are announced.

Other Announcement

Trustwave Securities Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Annual General Meeting

Trustwave Securities Annual General Meeting

Trustwave Securities Limited held its 42nd Annual General Meeting on September 24, 2026, via video conferencing. The meeting covered adoption of financial statements and director re-appointment.

Board Meeting Date

Trustwave Securities Board Meeting Date

Trustwave Securities scheduled a board meeting on May 28, 2026, to approve audited financial results. Trading window remains closed until 48 hours post-announcement.

Debt & Borrowing

Trustwave Securities Debt & Borrowing: ₹2.19 Cr

Trustwave Securities Ltd confirmed it is not a 'Large Corporate' as of March 31, 2026, per SEBI framework criteria. The company reported outstanding borrowings of ₹2.19 Crore, exempting it from specific debt-sourcing requirements for the financial year.

Value

₹2.19 Cr

Board Meeting Outcome

Trustwave Securities Board Meeting Outcome

Trustwave Securities Limited approved the allotment of 3,26,880 new equity shares to implement a capital reduction scheme approved by the NCLT Mumbai Bench. Following this allotment, the company's paid-up capital stands at Rs. 32.68 Lakhs (3,26,880 shares). The record date for this corporate action was April 27, 2026.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.